InvestorsHub Logo

Cherry_11

01/29/18 5:29 PM

#214799 RE: DaubersUP #214760

Great day here. Should be the start of the ascent to new all time highs this year. $$.

So many irons in the fire. Can’t believe we had the opportunity to load at these levels.

Expecting $1 billion dollar market cap or more by years end.

petemantx

01/29/18 6:13 PM

#214806 RE: DaubersUP #214760

Top123's post 214697 shows why everyone has been way, way too conservative on the value of the B platform. It's uses are so widespread that no current valuation is possible.

To have a product that can be incorporated into textiles, paints, plastics, etc, etc means that B will have an ungodly amount of universal applications not involving patients per se.

Instead of a product that is ingested or aimed at specific patients, it will be incorporated into a plethora of products across a wide spectrum of everyday life for everyone on the planet making all of these products antimicrobial.

Many are reluctant to give a value of the B platform because they will be ridiculed by those with agendas against the company, but IMO B could become one of the largest industrial components in the world in addition to being one of the largest drugs in the world of medicine.

I also believe we will find Kevetrin following a path the likes of B in that it is going to be found to be so compatible with so many other medical products that it will startle everyone.

wsbc

02/04/18 1:19 PM

#215769 RE: DaubersUP #214760

I guess we'll see what happens. I came up with something around a little over $40/pps for B-OM (ballpark), and Prur is a wildcard. Totally depends on results. One thing that folks aren't thinking about is who's running the show at IPIX, and their history in different market-segments. This is critical when cross-referencing for different indications and some of the other stuff they're looking at related to topline results ;) (just sayin'). I think some folks will be surprised what gets this thing moving.